Acumen Pharmaceuticals (ABOS) Capital Expenditures (2021 - 2025)
Acumen Pharmaceuticals (ABOS) reported Capital Expenditures of $9000.0 for Q2 2025, up 80.0% on a YoY basis from $5000.0 in Q2 2024, and down 88.61% sequentially from $79000.0 in Q1 2025.
Acumen Pharmaceuticals (ABOS) Capital Expenditures (2021 - 2025) Analysis & Trends
Acumen Pharmaceuticals (ABOS) has 5 years of Capital Expenditures data on file, last reported at $9000.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures rose 80.0% year-over-year to $9000.0; the trailing twelve-month figure through Mar 2026 stood at $9000.0 (down 89.29% YoY), and the FY2025 full-year result was $88000.0, up 450.0% from the prior year.
- Capital Expenditures slipped to $9000.0 in Q2 2025, from $79000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $84000.0 in Q3 2022 to a low of $5000.0 in Q2 2024.
- A 5-year average of $26666.7 and a median of $12500.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 950.0% in 2022 and sank 91.67% in 2023, its largest moves.
- Tracing ABOS's Capital Expenditures over 5 years: stood at $26000.0 in 2021, then jumped by 34.62% to $35000.0 in 2022, then tumbled by 60.0% to $14000.0 in 2023, then slumped by 64.29% to $5000.0 in 2024, then soared by 80.0% to $9000.0 in 2025.
- Business Quant data shows ABOS's Capital Expenditures at $9000.0 in Q2 2025, $79000.0 in Q1 2025, and $5000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Acumen Pharmaceuticals | 140.66 Mn | 140.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 33,000.00 |
| Jun 30, 2022 | 33,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Mar 31, 2022 | 9,000.00 |